- Tytuł :
- A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)
- Autorzy :
- Źródło :
- Cancer Immunology, Immunotherapy. 70(3):743-753
-
Czasopismo naukowe